Skip to main content
. 2020 May 19;20:302. doi: 10.1186/s12884-020-02997-7

Table 4.

Association between preeclampsia and maternal plasma TAMO concentration in the second trimester

PE type Quartile for TMAO concentration in the second trimester (μg/m3) p for trend Per 50 μg/m3 increment
Q1 (< 57.58) Q2 (57.58- < 84.80) Q3 (84.80- < 116.36) Q4 (≥116.36)
PE
 Case / Control 21/ 45 9/ 57 14/ 52 22/ 44
 OR (95%CI) Reference 0.34 (0.14, 0.81) 0.58 (0.26, 1.27) 1.07 (0.52, 2.22) 0.611 1.33 (0.98, 1.79)
 ORaadj (95%CI) Reference 0.30 (0.12, 0.75) 0.57 (0.24, 1.32) 1.00 (0.47, 2.14) 0.867 1.23 (0.90, 1.68)
EOPE
 Case / Control 6/ 45 3/ 57 4/ 52 4/ 44
 OR (95%CI) Reference 0.40 (0.09, 1.67) 0.58 (0.15, 2.17) 0.68 (0.18, 2.58) 0.643 0.89 (0.47, 1.67)
 ORaadj (95%CI) Reference 0.34 (0.08, 1.53) 0.52 (0.13, 2.18) 0.66 (0.16, 2.65) 0.372 0.75 (0.39, 1.44)
LOPE
 Case / Control 15/ 45 6/ 57 10/ 52 18/ 44
 OR (95%CI) Reference 0.32 (0.11, 0.88) 0.58 (0.24, 1.41) 1.23 (0.55, 2.74) 0.389 1.48 (1.06, 2.05)
 ORaadj (95%CI) Reference 0.40 (0.16, 1.00) 0.61 (0.24, 1.56) 1.12 (0.48, 2.59) 0.521 1.41 (1.00, 1.98)
Mild PE
 Case / Control 14/ 45 4/ 57 7/ 52 16/ 44
 OR (95%CI) Reference 0.23 (0.07, 0.73) 0.43 (0.16, 1.17) 1.17 (0.51, 2.68) 0.497 1.55 (1.09, 2.20)
 ORaadj (95%CI) Reference 0.25 (0.05, 1.19) 0.43 (0.15, 1.30) 1.19 (0.50, 2.86) 0.510 1.35 (0.69, 2.64)
Severe PE
 Case / Control 7/ 45 5/ 57 7/ 52 6/ 44
 OR (95%CI) Reference 0.56 (0.17, 1.90) 0.87 (0.28, 2.66) 0.88 (0.27, 2.82) 0.999 0.98 (0.58, 1.66)
 ORaadj (95%CI) Reference 0.53 (0.15, 1.87) 0.89 (0.26, 2.97) 0.71 (0.20, 2.50) 0.550 0.83 (0.48, 1.43)

a: Adjusted for year of education, pre-pregnancy BMI, smoking during pregnancy, fetal gender;

Abbreviation: TMAO trimethylamine-N-oxide; PE preeclampsia; EOPE early onset preeclampsia; LOPE late onset preeclampsia; OR odds ratio; CI confidence interval